drugIndia
Cart
Metosartan CH 25 Tablet ER

Metosartan CH 25 Tablet ER

Metoprolol Succinate (25mg) + Chlorthalidone (12.5mg) + Telmisartan (40mg)

Sun Pharmaceutical Industries Ltd
Hypertension
119.25149.0620% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
drugIndia verified
Save 23%
Best Alternative100% Match

Metocard-CHT 25 Tablet ER

Torrent Pharmaceuticals Ltd

Chlorthalidone 12.5mg
Metocard-CHT 25 Tablet ER

Pack Size

1 units

Price

91.3820% off
Metocard-CHT 25 Tablet ER is 100% same as Metosartan CH 25 Tablet ER
Better ValueSame QualitySame Effectiveness

Save ₹28

that's 23% off!

composition
  1. Chlorthalidone 12.5mg
  2. Metoprolol Succinate 25mg
  3. Telmisartan 40mg
Buy Now
119.2520% OFF
149.06

About This Medicine

Product description & overview

Metosartan CH 25 Tablet ER: A Combined Approach to Hypertension Management

Metosartan CH 25 Tablet ER is a highly effective medication designed for the long-term management of hypertension (high blood pressure). This combination therapy utilizes three key ingredients:

* Chlorthalidone: A diuretic that helps reduce fluid retention, lowering blood volume and thus decreasing pressure on artery walls.
* Metoprolol Succinate: A beta-blocker that slows down the heart rate and reduces the force of each heartbeat, further contributing to blood pressure control.
* Telmisartan: An angiotensin II receptor blocker that helps relax blood vessels, leading to lower blood pressure.

Metosartan CH 25 Tablet ER offers a comprehensive approach to hypertension management by addressing different aspects of the condition and reducing associated risk factors. It's important to discuss any concerns with your healthcare professional before starting or discontinuing this medication.

Note: This description is for informational purposes only and should not be considered medical advice. Consult a qualified healthcare provider before self-medicating.

Active composition

Metoprolol Succinate 25 mg

+2 more active ingredients

About Metoprolol Succinate

Metoprolol Succinate is a beta-blocker used to treat hypertension and heart-related conditions. It works by slowing the heart rate and reducing blood pressure. Metoprolol Succinate is clinically significant for managing cardiovascular health. In summary, metoprolol succinate is essential for controlling blood pressure and improving heart function.

How It Works

Metoprolol Succinate blocks beta-1 adrenergic receptors, leading to decreased heart rate and contractility, thereby lowering blood pressure.

Medicine Strength
25 mg

All Active Ingredients

Metoprolol Succinate25 mg
Chlorthalidone12.5 mg
Telmisartan40 mg

Telmisartan

Telmisartan selectively blocks angiotensin II receptors, leading to vasodilation and decreased blood pressure.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Metosartan CH 25 Tablet ER.

High Risk

Pregnancy

Metosartan CH 25 Tablet ER is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.

Medical Advice

Driving

Metosartan CH 25 Tablet ER may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

Exercise Caution

Liver

Metosartan CH 25 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Metosartan CH 25 Tablet ER may be needed. Please consult your doctor. Use of Metosartan CH 25 Tablet ER is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Metosartan CH 25 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Consult Doctor

Kidney

Metosartan CH 25 Tablet ER should be used with caution in patients with severe kidney disease. Dose adjustment of Metosartan CH 25 Tablet ER may be needed. Please consult your doctor. Use of Metosartan CH 25 Tablet ER is not recommended in these patients.

Regular Checkup

Customer Reviews

0 reviews for Metosartan CH 25 Tablet ER

Products matching your search